The Joshua Frase Foundation For Congenital Myopathy Research Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 111,669 | 96,784 | 14,885 | 11.1 | 0% |
| 2012 | 102,667 | 91,493 | 11,174 | 13.2 | 4% |
| 2013 | 121,599 | 132,719 | −11,120 | 8.1 | 12% |
| 2014 | 111,507 | 97,741 | 13,766 | 12.7 | 24% |
| 2015 | 102,457 | 113,874 | −11,417 | 9.7 | 28% |
| 2016 | 171,852 | 204,915 | −33,063 | 3.5 | 16% |
| 2017 | 210,309 | 141,054 | 69,255 | 10.9 | 39% |
| 2018 | 184,667 | 131,560 | 53,107 | 16.5 | 35% |
| 2019 | 85,200 | 154,269 | −69,069 | 8.7 | 42% |
| 2020 | 67,348 | 149,492 | −82,144 | 2.4 | 64% |
| 2021 | 213,958 | 155,324 | 58,634 | 6.9 | 61% |
| 2022 | 67,138 | 89,704 | −22,566 | 8.9 | 62% |
In its most recent public year (2022), this organization spent $22,566 more than it brought in. Its reserves stood at about 8.9 months of spending, down from 11.1 in 2011. Staff pay was 62% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2022. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
The Joshua Frase Foundation For Congenital Myopathy Research Inc's IRS filings as a feed — one entry per filing year, through 2022. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works